Keep an eye on Carefully (two)pentobarbital will decrease the level or outcome of suvorexant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check. Strong CYP3A4 inducers may lessen suvorexant efficacy; if improved suvorexant dose demanded, tend not to exceed twenty mg/working daypentobarbital will minimize the level or effect